China Medical System Secures Singapore Approval for Lumirix Cream to Treat Vitiligo

China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Rxilient Medical received ...

November 05, 2026 | Thursday | News
Rakovina Therapeutics and Celvion Use AI to Identify Priority Cancer Indications for ATR Inhibitor Development

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF), a biopharmaceutical company advancing innovative cancer therapies through AI-powered ...

October 30, 2026 | Friday | News
Exogenus Therapeutics Leads €13 Million European Project to Advance EXO-101 for Osteoarthritis

ExoCordOA, a five-year project, led by Exogenus Therapeutics and backed by Horizon Europe, brings together ten organisations spanning biotechnology, clin...

October 30, 2026 | Friday | News
CellsBin Wins NCI SBIR Award to Advance Blood-Based Multiple Myeloma Test

CellsBin®, a biotechnology company pioneering Rare-Cell Biology™, announced that it has received a Direct-to-Phase II Small Business Innov...

October 29, 2026 | Thursday | News
Kos Biotechnology Partners Invests in Golden Age Health to Expand Rare Disease Drug Access in Asia

Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President Kos Biotechnology Partners ("Kos"), a global ...

October 28, 2026 | Wednesday | News
Roche’s Divarasib Extends Survival in Phase 3 Trial for KRAS G12C-Mutated Lung Cancer

Divarasib monotherapy demonstrated superior efficacy over first-generation KRAS G12C inhibitors, lowering the risk of disease progression or death by 42%...

October 27, 2026 | Tuesday | News
Okomera Partners with Servier to Advance Cancer Drug Development Using Tumour Modelling Technology

Okomera reaches a key milestone in its industrial rollout with the first commercial installation of its integrated platform, combining hardware, softwa...

October 22, 2026 | Thursday | News
FDA Approves GSK and Ionis’ Hibsago for Chronic Hepatitis B Treatment

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for t...

October 22, 2026 | Thursday | News
Anteris Technologies Secures German Regulatory Clearance for DurAVR Heart Valve Trial

Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) announced that it has received full regulato...

October 21, 2026 | Wednesday | News
Lundbeck Advances Lu AF28996 into Phase II Trial for Advanced Parkinson’s Disease

Managing motor fluctuations and dyskinesia remains a significant challenge for people living with advanced Parkinson's disease, despite advances in existin...

October 20, 2026 | Tuesday | Interview
Rhythm Pharmaceuticals Launches IMCIVREE in Japan for Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living ...

October 15, 2026 | Thursday | News
InnoCare Wins China Approval for Phase 3 Mesutoclax Study in MZL

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced that...

October 14, 2026 | Wednesday | News
FDA Grants Fast Track Status to Leads Biolabs’ Opamtistomig in Biliary Tract Cancer

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) announced that the U.S. Food and Drug Admin...

October 13, 2026 | Tuesday | News
Axplora Advances Axotecan to Establish European Exatecan Supply for ADC Developers

Independent European source of exatecan will expand choice and strengthen supply resilience for ADC developers Gram-scale material available, with...

October 08, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close